Boothbay Fund Management, LLC Chemo Centryx, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

$3.6 Billion
Q3 2024

Call Options

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $1.42 Million - $2.54 Million	92,500 New	92,500 $2.29 Million
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $1.5 Million - $3.31 Million	-81,700 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $732,808 - $1.1 Million	55,600 Added 213.03%	81,700 $1.4 Million
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $250,299 - $1.33 Million	26,100 New	26,100 $349,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.